Changes between Initial Version and Version 1 of Research/DesignStudy/Meetings/2020/2020-01-28


Ignore:
Timestamp:
Jan 27, 2020, 4:37:40 PM (5 years ago)
Author:
kurup
Comment:

--

Legend:

Unmodified
Added
Removed
Modified
  • Research/DesignStudy/Meetings/2020/2020-01-28

    v1 v1  
     1= LhARA pre-CDR Meeting 21st Jan 2020 =
     2
     3== Meeting details ==
     4
     515:00 Room 532, Blackett Lab.
     6
     7Zoom details:
     8
     9 Join Zoom Meeting https://ukri.zoom.us/j/865262978
     10
     11 Phone one-tap:
     12 United Kingdom: +442034815237!,,865262978# or +442039663809!,,865262978#
     13
     14 Join by Telephone For higher quality, dial a number based on your current location.
     15    United Kingdom:
     16      +44 203 481 5237\\
     17      +44 203 966 3809\\
     18      +44 131 460 1196\\
     19      +44 203 051 2874
     20      0800 031 5717
     21 Meeting ID: 865 262 978
     22
     23 Join from an H.323/SIP room system H.323: 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India) 213.19.144.110 (EMEA) 103.122.166.55 (Australia) 209.9.211.110 (Hong Kong) 64.211.144.160 (Brazil) 69.174.57.160 (Canada) 207.226.132.110 (Japan)
     24 Meeting ID: 865 262 978
     25
     26
     27 International numbers https://ukri.zoom.us/u/ap9aBI2Eh
     28
     29 SIP: 865262978@zoomcrc.com \\
     30 Skype for Business (Lync) https://ukri.zoom.us/skype/865262978 \\
     31 Skype on a SurfaceHub SIP: 865262978@lync.zoom.us https://ukri.zoom.us/skype/865262978
     32
     33
     34== Agenda ==
     35 * Action items from last meeting.
     36  * AK to add Colin's note to the wiki.
     37  * JPas to send AK beta and alpha as a function of S (calculated by BeamOptics).
     38
     39
     40 * System updates.
     41  * Laser driven proton and ion source.
     42  * Proton and ion capture.
     43  * Stage 1 beam transport: Beam transport and delivery to the in vitro end station.
     44  * Stage 2 beam transport: Post-acceleration and beam delivery to the in vivo end station.
     45  * Biological end stations.
     46  * Infrastructure and Integration.
     47  * Project plan for the delivery of LhARA.
     48  * Safety.
     49  * End-to-end simulation.
     50  * Instrumentation.
     51 * A.O.B.
     52
     53== Notes ==
     54Participants:\\
     55Apologies: \\
     56
     57   
     58== Action Items ==